JPH11502520A - 難水溶性の光増感性化合物の投与に適した乳濁液及びその使用 - Google Patents
難水溶性の光増感性化合物の投与に適した乳濁液及びその使用Info
- Publication number
- JPH11502520A JPH11502520A JP8527094A JP52709496A JPH11502520A JP H11502520 A JPH11502520 A JP H11502520A JP 8527094 A JP8527094 A JP 8527094A JP 52709496 A JP52709496 A JP 52709496A JP H11502520 A JPH11502520 A JP H11502520A
- Authority
- JP
- Japan
- Prior art keywords
- emulsion
- oil
- emulsion according
- compound
- pyrrole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Colloid Chemistry (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 難水溶性で薬学的に活性な光増感性化合物を患者に投与するための乳濁液 で、親水性相に分散する疎水性相としての薬学的に許容される脂質、有効量の前 記光増感性化合物、安定剤、並びに、補助安定剤としての、コール酸、デオキシ コール酸、グリココール酸及びこれらの混合物からなる群より選択される胆汁酸 の塩からなる乳濁液。 2. 前記難水溶性の光増感性化合物は、ピロール系大環状化合物である請求項 1記載の乳濁液。 3. 前記脂質は、大豆油、紅花油、魚油、クロスグリ種子油、ルリチシャ油、 パーム油、ひまわり油、綿実油、オリーブ油、ココナッツ油及びこれらの物理的 混合物又は相互エステル化混合物からなる群より選択される請求項1記載の乳濁 液。 4. 前記脂質は、脂肪酸が8〜10個の炭素鎖を有するトリグリセリドである 請求項1記載の乳濁液。 5. 前記脂質は、ココナッツ油から蒸留したトリグリセリドである請求項1記 載の乳濁液。 6. 前記安定剤は、卵黄リン脂質である請求項1記載の乳濁液。 7. 乳濁粒子は、5ミクロン以下の平均粒径を有する請求項1記載の乳濁液。 8. 前記粒径は、0.5ミクロン以下である請求項1記載の乳濁液。 9. 前記光増感性化合物の量は約0.01〜約1g/100mlであり、前記 脂質の量は約5〜約40g/100mlであり、前記胆汁酸塩の量は約0.05 〜約0.4g/100mlである請求項1記載の乳濁液。 10. 前記安定剤の量は、約0.3〜約3g/100mlである請求項1記載 の乳濁液。 11. 更に、等張剤を含有する請求項1記載の乳濁液。 12. 前記等張剤は、約0.4〜約4g/100mlの量で含有される請求項 11記載の乳濁液。 13. 前記等張剤は、グリセリンである請求項11記載の乳濁液。 14. 更に、酸化防止剤を含有する請求項1記載の乳濁液。 15. 前記酸化防止剤は、約0.02〜約0.2g/100mlの量で含有さ れる請求項14記載の乳濁液。 16. 前記酸化防止剤は、α−トコフェロールである請求項14記載の乳濁液 。 17. 前記胆汁酸の塩は、コール酸の塩である請求項1記載の乳濁液。 18. 前記塩は、コール酸ナトリウムである請求項17記載の乳濁液。 19. 更に、エチルアルコールを含有する請求項1記載の乳濁液。 20. 前記エチルアルコールの量は、約0.2〜2g/100mlである請求 項19記載の乳濁液。 21. 前記ピロール系大環状化合物は、少なくとも1つの天然又は合成のポル フィリン、天然又は合成のクロリン、天然又は合成のバクテリオクロリン、合成 のイソバクテリオクロリン、フタロシアニン、ナフタロシアニン、並びに、ポル フィセン、サプフィリン及びテキサフィリン等の拡大されたピロール系大環状化 合物、並びに、これらの誘導体からなる群より選択される請求項2記載の乳濁液 。 22. 前記ピロール系大環状化合物は、エチルエチオプルプリンスズ〔SnE t2〕である請求項21記載の乳濁液。 23. 前記ピロール系大環状化合物は、フタロシアニン亜鉛である請求項21 記載の乳濁液。 24. 前記ピロール系大環状化合物は、ベンゾポルフィリン誘導体〔BPD〕 である請求項21記載の乳濁液。 25. 前記ピロール系大環状化合物は、メソ−テトラ(ヒドロキシフェニル) クロリンである請求項21記載の乳濁液。 26. 請求項1記載の乳濁液の有効量を患者に投与することからなる、光増感 性化合物で前記患者を治療する方法。 27. 前記投与は、静脈注射である請求項26記載の方法。 28. 更に、前記ピロール系大環状化合物を活性化させるために、投与後に前 記化合物を光に曝すことからなる請求項26記載の方法。 29. 請求項1記載の乳濁液の有効量を患者に投与し、次いで、前記患者の対 象組織に優先的に保持されている光増感性化合物の蛍光を誘発することができる 適切な波長の光線に前記患者を曝すことからなる、前記患者の病気の診断方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/419,911 US5616342A (en) | 1995-04-11 | 1995-04-11 | Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
US08/419,911 | 1995-04-11 | ||
PCT/US1996/004971 WO1996032094A1 (en) | 1995-04-11 | 1996-04-10 | Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11502520A true JPH11502520A (ja) | 1999-03-02 |
Family
ID=23664263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8527094A Ceased JPH11502520A (ja) | 1995-04-11 | 1996-04-10 | 難水溶性の光増感性化合物の投与に適した乳濁液及びその使用 |
Country Status (16)
Country | Link |
---|---|
US (1) | US5616342A (ja) |
EP (1) | EP0825851B1 (ja) |
JP (1) | JPH11502520A (ja) |
AR (1) | AR001602A1 (ja) |
AT (1) | ATE270543T1 (ja) |
AU (1) | AU706848B2 (ja) |
CA (1) | CA2217573C (ja) |
DE (1) | DE69632858T2 (ja) |
ES (1) | ES2225880T3 (ja) |
IL (1) | IL117990A (ja) |
MY (1) | MY116509A (ja) |
NO (1) | NO321260B1 (ja) |
PT (1) | PT825851E (ja) |
TW (1) | TW505526B (ja) |
WO (1) | WO1996032094A1 (ja) |
ZA (1) | ZA962854B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627288B1 (en) | 2000-08-10 | 2003-09-30 | Mitsui Chemicals, Inc. | Optical recording medium and porphycene compound |
JP2022533837A (ja) * | 2019-05-20 | 2022-07-26 | ポビバ コーポレーション | 生物活性物質と胆汁酸塩を含む組成物 |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6210356B1 (en) * | 1998-08-05 | 2001-04-03 | Ekos Corporation | Ultrasound assembly for use with a catheter |
US6176842B1 (en) | 1995-03-08 | 2001-01-23 | Ekos Corporation | Ultrasound assembly for use with light activated drugs |
US6375930B2 (en) | 1996-06-04 | 2002-04-23 | Board Of Regents, The University Of Texas System | Membrane incorporation of texaphyrins |
US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
JP2001511128A (ja) * | 1997-01-28 | 2001-08-07 | ファルマシア・アンド・アップジョン・カンパニー | 水不溶性ポルフィリンの脂質錯体の凍結乾燥物 |
US6676626B1 (en) | 1998-05-01 | 2004-01-13 | Ekos Corporation | Ultrasound assembly with increased efficacy |
US6582392B1 (en) | 1998-05-01 | 2003-06-24 | Ekos Corporation | Ultrasound assembly for use with a catheter |
US6054421A (en) * | 1997-09-23 | 2000-04-25 | Scimed Life Systems, Inc. | Medical emulsion lubricant |
US6281175B1 (en) | 1997-09-23 | 2001-08-28 | Scimed Life Systems, Inc. | Medical emulsion for lubrication and delivery of drugs |
US6316215B1 (en) | 1999-12-27 | 2001-11-13 | Edwin L. Adair | Methods of cancer screening utilizing fluorescence detection techniques and selectable imager charge integration periods |
US7030155B2 (en) | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US8267982B2 (en) | 1998-08-25 | 2012-09-18 | Advanced Photodynamic Technologies, Inc. | Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
US7229447B1 (en) | 1998-08-25 | 2007-06-12 | Advanced Photodynamics Technologies, Inc. | Photodynamic therapy utilizing a solution of photosensitizing compound and surfactant |
DE19852245A1 (de) * | 1998-11-12 | 2000-05-18 | Asat Ag Applied Science & Tech | 5-Aminolävulinsäure-Nanoemulsion |
IT1303603B1 (it) | 1998-12-16 | 2000-11-14 | Giovanni Sacco | Procedimento a tassonomia dinamica per il reperimento di informazionisu grandi banche dati eterogenee. |
US6956048B2 (en) * | 1999-03-31 | 2005-10-18 | Pharmacia & Upjohn Company | Pharmaceutical emulsions for retroviral protease inhibitors |
US7389351B2 (en) * | 2001-03-15 | 2008-06-17 | Microsoft Corporation | System and method for identifying and establishing preferred modalities or channels for communications based on participants' preferences and contexts |
US6608050B2 (en) | 1999-07-20 | 2003-08-19 | Pharmacia & Upjohn Company | Lyophilizate of lipid complex of water insoluble porphyrins |
US6720001B2 (en) | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
US6190877B1 (en) | 1999-12-27 | 2001-02-20 | Edwin L. Adair | Method of cancer screening primarily utilizing non-invasive cell collection and fluorescence detection techniques |
US6984498B2 (en) * | 1999-12-27 | 2006-01-10 | Adair Edwin L | Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques |
US6750037B2 (en) * | 1999-12-27 | 2004-06-15 | Edwin L. Adair | Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques |
WO2001085213A2 (en) * | 2000-05-08 | 2001-11-15 | The University Of British Columbia | Supports for photosensitizer formulations |
AU2001258095A1 (en) * | 2000-05-08 | 2001-11-20 | The University Of British Columbia | Drug delivery systems for photodynamic therapy |
US6605606B1 (en) * | 2000-08-04 | 2003-08-12 | Miravant Pharmaceuticals, Inc. | Solid forms of tin ethyl etiopurpurin and processes for producing such forms |
US20030212052A1 (en) * | 2001-04-20 | 2003-11-13 | David Kessel | Use of ursdeoxycholic acid for potentiation of the phototoxic effect of photodynamic therapy |
EP1277470A1 (fr) * | 2001-07-17 | 2003-01-22 | Steba Biotech N.V. | Formulation galénique injectable pour utilisation dans un diagnostic ou une thérapie photodynamique et son procédé de préparation |
ATE319378T1 (de) | 2001-12-03 | 2006-03-15 | Ekos Corp | Katheter mit mehreren ultraschall-abstrahlenden teilen |
US8226629B1 (en) | 2002-04-01 | 2012-07-24 | Ekos Corporation | Ultrasonic catheter power control |
EP1374912B1 (en) * | 2002-06-21 | 2006-08-16 | Edwin L. Adair | Use of metaloporphyrins for treatment of arteriosclerotic lesions |
US6921371B2 (en) * | 2002-10-14 | 2005-07-26 | Ekos Corporation | Ultrasound radiating members for catheter |
US20050186230A1 (en) * | 2004-01-23 | 2005-08-25 | Sd Pharmaceuticals, Inc. | Elemene compositions containing liquid oil |
US8709449B2 (en) * | 2004-02-12 | 2014-04-29 | Biolitec Pharma Marketing Ltd | Methods and compositions for improving photodynamic therapy through administration of lipids |
US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
EP2422789B1 (en) | 2004-05-19 | 2017-11-22 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Injectable coposition comprising sodium deoxycholate |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
US7825153B2 (en) * | 2004-08-16 | 2010-11-02 | Ceramoptec Industries, Inc. | Photosensitizer formulations and their use |
JP4462051B2 (ja) * | 2005-01-28 | 2010-05-12 | 富士ゼロックス株式会社 | 微粒子分散液の濃縮方法、及び微粒子分散液の濃縮装置 |
WO2007035311A2 (en) * | 2005-09-16 | 2007-03-29 | University Of Massachusetts Lowell | Anti-oxidant synergy formulation nanoemulsions to treat cancer |
US10182833B2 (en) | 2007-01-08 | 2019-01-22 | Ekos Corporation | Power parameters for ultrasonic catheter |
PL2170181T3 (pl) | 2007-06-22 | 2014-08-29 | Ekos Corp | Sposób i aparat do leczenia wylewów wewnątrzczaszkowych |
EP2231024A4 (en) * | 2007-12-14 | 2015-03-18 | Ekos Corp | ULTRASOUND PULSE SHAPING |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
MX363465B (es) | 2011-02-18 | 2019-03-25 | Kythera Biopharmaceuticals Inc | Tratamiento de la grasa submental. |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
EP3307388B1 (en) | 2015-06-10 | 2022-06-22 | Ekos Corporation | Ultrasound catheter |
US10723694B2 (en) * | 2018-10-02 | 2020-07-28 | Kuwait University | Propargyl-functionalized macrocyclic compounds |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1792410B2 (de) * | 1967-09-01 | 1980-03-13 | Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm | Arzneimittelzubereitung zur intravenösen Injektion |
US4115313A (en) * | 1974-10-08 | 1978-09-19 | Irving Lyon | Bile acid emulsions |
JPS6030652B2 (ja) * | 1979-05-07 | 1985-07-17 | 株式会社ミドリ十字 | 静脈注射用脂肪乳剤 |
DE3339236A1 (de) * | 1983-10-28 | 1985-05-09 | Bayer Ag | Arzneimittelzubereitung |
US4703062A (en) * | 1984-01-16 | 1987-10-27 | Baxter Travenol Laboratories, Inc. | Parenteral nutrition with medium and long chain triglycerides |
US4816247A (en) * | 1985-09-11 | 1989-03-28 | American Cyanamid Company | Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs |
US4784845A (en) * | 1985-09-16 | 1988-11-15 | American Cyanamid Company | Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs |
JPS62270521A (ja) * | 1986-05-16 | 1987-11-24 | Green Cross Corp:The | フルルビプロフエン眼投与製剤 |
US4877872A (en) * | 1986-06-24 | 1989-10-31 | The University Of Toledo | Production and use of dimers of hematoporophyrin, purpurins, chlorines and purpurin- and chlorin-complexes |
US4914088A (en) * | 1987-04-02 | 1990-04-03 | Thomas Glonek | Dry eye treatment solution and method |
FR2619505B1 (fr) * | 1987-08-20 | 1990-08-31 | Dior Christian Parfums | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant |
US5109129A (en) * | 1989-09-29 | 1992-04-28 | The University Of Toledo, Medical College Of Ohio | Porphyrin derivatives |
CA1341460C (en) * | 1988-01-11 | 2004-10-19 | The Medical College Of Ohio | Production and use of porphyrin derivatives and of compositions containing such derivates |
US5250668A (en) * | 1988-01-11 | 1993-10-05 | Morgan Alan R | Production and use of porphyrin derivatives and of compositions containing such derivatives |
EP0361928B1 (en) * | 1988-09-29 | 1994-04-27 | Shiseido Company Limited | Emulsified composition |
US5364632A (en) * | 1989-04-05 | 1994-11-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
AU614465B2 (en) * | 1989-04-05 | 1991-08-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
JPH0832638B2 (ja) * | 1989-05-25 | 1996-03-29 | カイロン コーポレイション | サブミクロン油滴乳剤を含んで成るアジュバント製剤 |
ES2084722T3 (es) * | 1990-05-29 | 1996-05-16 | Boston Ocular Res | Composicion para tratamiento del ojo seco. |
CA2052950A1 (en) * | 1990-10-10 | 1992-04-11 | David P. Evitts | Aqueous ophthalmic microemulsions of tepoxalin |
US5244671A (en) * | 1991-01-29 | 1993-09-14 | Cytopharm, Inc. | Derivatives of porphycene for photodynamic therapy of cancer |
US5179120A (en) * | 1991-06-28 | 1993-01-12 | Cytopharm, Inc. | Porphycene compounds for photodynamic therapy |
US5286474A (en) * | 1992-10-22 | 1994-02-15 | Arizona Board Of Regents, A Body Corporate, Acting For And On Behalf The Arizona State University | Use of carotenoporphyrins as tumor localizing agents for diagnosis |
-
1995
- 1995-04-11 US US08/419,911 patent/US5616342A/en not_active Expired - Lifetime
-
1996
- 1996-04-03 MY MYPI96001233A patent/MY116509A/en unknown
- 1996-04-10 ES ES96912671T patent/ES2225880T3/es not_active Expired - Lifetime
- 1996-04-10 EP EP96912671A patent/EP0825851B1/en not_active Expired - Lifetime
- 1996-04-10 WO PCT/US1996/004971 patent/WO1996032094A1/en active IP Right Grant
- 1996-04-10 CA CA002217573A patent/CA2217573C/en not_active Expired - Fee Related
- 1996-04-10 AT AT96912671T patent/ATE270543T1/de not_active IP Right Cessation
- 1996-04-10 JP JP8527094A patent/JPH11502520A/ja not_active Ceased
- 1996-04-10 ZA ZA962854A patent/ZA962854B/xx unknown
- 1996-04-10 DE DE69632858T patent/DE69632858T2/de not_active Expired - Fee Related
- 1996-04-10 PT PT96912671T patent/PT825851E/pt unknown
- 1996-04-10 AU AU55401/96A patent/AU706848B2/en not_active Ceased
- 1996-04-11 AR AR33613096A patent/AR001602A1/es active IP Right Grant
- 1996-04-21 IL IL11799096A patent/IL117990A/xx active IP Right Grant
- 1996-07-09 TW TW085108284A patent/TW505526B/zh not_active IP Right Cessation
-
1997
- 1997-10-06 NO NO19974615A patent/NO321260B1/no unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627288B1 (en) | 2000-08-10 | 2003-09-30 | Mitsui Chemicals, Inc. | Optical recording medium and porphycene compound |
JP2022533837A (ja) * | 2019-05-20 | 2022-07-26 | ポビバ コーポレーション | 生物活性物質と胆汁酸塩を含む組成物 |
Also Published As
Publication number | Publication date |
---|---|
US5616342A (en) | 1997-04-01 |
EP0825851B1 (en) | 2004-07-07 |
ZA962854B (en) | 1996-10-11 |
TW505526B (en) | 2002-10-11 |
DE69632858D1 (de) | 2004-08-12 |
WO1996032094A1 (en) | 1996-10-17 |
NO974615L (no) | 1997-10-06 |
MY116509A (en) | 2004-02-28 |
NO321260B1 (no) | 2006-04-10 |
ES2225880T3 (es) | 2005-03-16 |
ATE270543T1 (de) | 2004-07-15 |
AR001602A1 (es) | 1997-11-26 |
EP0825851A4 (en) | 2000-08-09 |
AU706848B2 (en) | 1999-06-24 |
NO974615D0 (no) | 1997-10-06 |
EP0825851A1 (en) | 1998-03-04 |
IL117990A0 (en) | 1996-08-04 |
DE69632858T2 (de) | 2005-09-01 |
PT825851E (pt) | 2004-11-30 |
IL117990A (en) | 2001-01-28 |
CA2217573A1 (en) | 1996-10-17 |
AU5540196A (en) | 1996-10-30 |
CA2217573C (en) | 2001-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11502520A (ja) | 難水溶性の光増感性化合物の投与に適した乳濁液及びその使用 | |
EP0660712B1 (en) | Transcutaneous in vivo activation of photosensitive agents in blood | |
JP5154296B2 (ja) | 疎水性薬物のための薬物送達系 | |
EP1030686B1 (en) | Lyophilizate of lipid complex of water insoluble porphyrins | |
KR100887785B1 (ko) | 광역학적 치료를 위한 비극성 감광제 제형 | |
US8815931B2 (en) | Oral formulations for tetrapyrrole derivatives | |
AU604288B2 (en) | Phospholipid delivery vehicle for aqueous-insoluble active ingredients | |
US20060127471A1 (en) | Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy | |
US6608050B2 (en) | Lyophilizate of lipid complex of water insoluble porphyrins | |
EP1465590B1 (en) | Micelle compositions containing pegylated phospholipids and a photosensitizer | |
US8709449B2 (en) | Methods and compositions for improving photodynamic therapy through administration of lipids | |
Morgan et al. | In vivo cytotoxicity of Metallopurpurins to Bladder Tumors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061114 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20061122 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20061124 |
|
RD13 | Notification of appointment of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7433 Effective date: 20061124 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20061204 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070122 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20070627 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070807 |